-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-choosing-outcomes.ppt
June 01, 2012 - Determine the group to which the testing outcomes are most relevant. … consideration; and (5) the costs of testing. … Additional patient outcomes and pathways in evaluations of testing. … consideration; and (5) the costs of testing. … Genetic Testing
Segal JB.
-
effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-choosing-outcomes.ppt
June 01, 2012 - Determine the group to which the testing outcomes are most relevant. … consideration; and (5) the costs of testing. … Additional patient outcomes and pathways in evaluations of testing. … consideration; and (5) the costs of testing. … Genetic Testing
Segal JB.
-
effectivehealthcare.ahrq.gov/products/wireless-motility-capsule/research-protocol
March 14, 2012 - Whether it can replace or should supersede other testing methods is controversial. … An advantage of colon scintigraphy is that testing can be completed in 1 to 2 days. … Other testing might be required to ensure that no narrowing is present. … , then the next step in evaluation is transit testing with use of laxatives. … motility capsule testing, and identify them for physicians and payers.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antibiotics-respiratory-infection_clinician.pdf
March 01, 2016 - While procalcitonin point-of-care testing reduced
antibiotic prescribing in adults, use of an adult … Clinical Interventions (Point-of-Care Testing):
��Procalcitonin point-of-care testing in adults reduced … ��Streptococcal antigen point-of-care testing (rapid strep
testing) reduced overall prescribing by 20 … ��Point-of-care testing for influenza in children had no
effect on antibiotic prescribing (���). … strep testing 3 RCTs ���
Inappropriate prescribing -33% Greater reduction with rapid strep testing 1
-
effectivehealthcare.ahrq.gov/health-topics/c%C3%A1ncer-0
December 08, 2017 - 2006-2009
Research Report
August 26, 2011
Data Points #15: Prognostic factor testing … Cancer Quality-ASSIST Supportive Oncology Quality Indicator Set: Feasibility, Reliability, and Validity Testing
-
effectivehealthcare.ahrq.gov/sites/default/files/coronary-artery-disease-testing_disposition-comments.pdf
March 29, 2016 - Peer Reviewer 1 Methods However it would be helpful to include testing vs no testing in
low risk groups … We identified no studies evaluating testing
versus no testing that met our inclusion
criteria. … testing as analyzed in this report. … There were no studies identified that
evaluated testing versus no testing in the
population of interest … No studies comparing testing
vs. no testing were identified.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0068_01-30-2009.pdf
January 01, 2009 - Results of Topic Selection Process & Next Steps
Antinuclear autoantibody and rheumatoid factor testing … is interested in the diagnostic accuracy of antinuclear antibody (ANA)
and rheumatoid factor (RF) testing … clinical factors that may modify accuracy or benefits and
harms associated with obtaining ANA and RF testing … not limited to):
Patient referrals (i.e., to pediatric rheumatologists)
Additional diagnostic testing … (e.g., radiologic studies, laboratory testing, etc
-
effectivehealthcare.ahrq.gov/products/antibiotics-respiratory-infection/clinician
April 06, 2016 - for procalcitonin testing in children increased antibiotic prescribing and adverse consequences. … Clinical Interventions (Point-of-Care Testing):
Procalcitonin point-of-care testing in adults reduced … Streptococcal antigen point-of-care testing (rapid strep testing) reduced overall prescribing by 20 to … Rapid viral point-of-care testing (multi-viral PCR) in adults reduced overall prescribing by 8 percent … consequences
—
[evidence insufficient]
Rapid viral point-of-care testing (multi-viral PCR) vs.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-4.pdf
July 01, 2019 - Quantifying, Testing, and Exploring Statistical Heterogeneity
Quantitative Synthesis
Chapter 4. … Quantifying, Testing, and Exploring
Statistical Heterogeneity
Prepared for:
The Agency for Healthcare … incorporate the subgroup factor into a meta-regression
framework.20
− This enables formal statistical testing … , allows for quantification of heterogeneity
and testing for residual heterogeneity.
20. … Quantifying, Testing, and Exploring �Statistical Heterogeneity
Learning objective
Statistical heterogeneity
-
effectivehealthcare.ahrq.gov/products/cancer-end-of-life-quality-meaures
May 17, 2010 - Testing Cancer Quality Measures for End of Life Care
Timeline
January 01, 2005
Topic … Initiated
May 17, 2010
Research Report
Archived
Testing Cancer
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-screening_research-protocol.pdf
May 18, 2011 - Practice Center Systematic Review Protocol
Project Title: Comparative Effectiveness of Fecal DNA Testing … (FOBT) or fecal immunohistochemical testing (FIT)
annually; and flexible sigmoidoscopy every 5 years … .
3
Fecal DNA testing detects molecular alterations associated with CRC development in
cellular … Question 6: Harms
What are the potential harms of fecal DNA testing? … FOBT = Fecal Occult-Blood Testing
USPSTF = U.S.
-
effectivehealthcare.ahrq.gov/products/genetic-tests-validity-rating-evaluation/research
June 16, 2011 - Structured Abstract
Objectives
This project pursued four objectives related to genetic testing: ( … 1) assess the feasibility of clarifying a set of evaluation frameworks for common testing scenarios; … Consequently, a set of analytic frameworks for common genetic testing scenarios (diagnosis, screening … , prognosis assessment, treatment monitoring, pharmacogenetics, risk/susceptibility assessment, and testing … Significant gaps were identified in evidence on genetic testing variability.
-
effectivehealthcare.ahrq.gov/products/prostate-cancer-antigen-3-gene
April 01, 2013 - PCA3 Testing in the Diagnosis and Management of Prostate Cancer: Future Research Needs … Topic Initiated
April 01, 2013
Systematic Review
Archived
PCA3 Testing
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-testing-machine-learning-tool-chronic-pain.pdf
November 01, 2020 - Methods Research Report: Testing a Machine Learning Tool for Facilitating Living Systematic Reviews of … Chronic Pain Treatments
Methods Research Report
Testing a Machine Learning … Systematic Reviews of Chronic Pain Treatments
Methods Research Report
Testing … Testing a Machine Learning Tool for
Facilitating Living Systematic Reviews of Chronic Pain Treatments … Standard (MeSH and text word) search strategy testing ...............................................
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay-future_research.pdf
September 01, 2012 - Intervention SFLC testing and SFLC testing in
combination with traditional testing. … SFLC testing and SFLC testing in combination with
traditional testing. … Intervention SFLC testing, metrics of SFLC testing,
frequency of SFLC testing.
SFLC testing. … SFLC testing and SFLC testing in
combination with traditional testing. … Intervention SFLC testing, metrics of SFLC testing, frequency of SFLC
testing
SFLC testing.
-
effectivehealthcare.ahrq.gov/products/study-design-classification
January 04, 2011 - Developing and Testing a Tool for the Classification of Study Designs in Systematic Reviews of Interventions … Initiated
January 04, 2011
Research Report
Developing and Testing
-
effectivehealthcare.ahrq.gov/products/dcis-prognostic-tests
September 13, 2012 - Data Points #15: Prognostic factor testing among older women with ductal carcinoma in situ and early … September 13, 2012
Research Report
Data Points #15: Prognostic factor testing
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/wireless-motility-capsule_research-protocol.pdf
March 14, 2012 - Whether it can replace or should
supersede other testing methods is controversial. … An advantage of colon scintigraphy is that testing can be completed
in 1 to 2 days. … Capsule testing cannot be performed in any
patient expected to have stricture or stenosis. … Other testing might be required to ensure that no
narrowing is present. … , then the next step in evaluation is transit testing with use of laxatives.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antiplatelet-treatment_research-protocol.pdf
November 22, 2011 - the use of testing (e.g., genetic testing to determine CYP2C19 status or phenotypic testing of
platelet … Genetic testing for CYP2C19
ii. … Genetic testing for CYP2C19 followed by phenotypic testing for
platelet reactivity
iii. … Phenotypic testing for platelet reactivity
iv. No testing
b. … Potential test-and-treat strategies will include testing for CYP2C19 genetic
variants, testing for
-
effectivehealthcare.ahrq.gov/products/grades-predictive-values
March 31, 2015 - Testing the Predictive Validity of Strength of Evidence Grades
Timeline
October 29, … Grades: A Meta-Epidemiological Study
September 14, 2015
Abstract
Testing